↓ Skip to main content

Poor tuberculosis treatment outcomes in Southern Mozambique (2011–2012)

Overview of attention for article published in BMC Infectious Diseases, May 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
131 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Poor tuberculosis treatment outcomes in Southern Mozambique (2011–2012)
Published in
BMC Infectious Diseases, May 2016
DOI 10.1186/s12879-016-1534-y
Pubmed ID
Authors

Alberto L. García-Basteiro, Durval Respeito, Orvalho J. Augusto, Elisa López-Varela, Charfudin Sacoor, Victor G. Sequera, Aina Casellas, Quique Bassat, Ivan Manhiça, Eusebio Macete, Frank Cobelens, Pedro L. Alonso

Abstract

In Mozambique, there is limited data regarding the monitoring of Tuberculosis (TB) treatment results and determinants of adverse outcomes under routine surveillance conditions. The objectives of this study were to evaluate treatment outcomes among TB patients, analyze factors associated with a fatal outcome and determine the proportion of deaths attributable to TB in the district of Manhiça, Southern Mozambique. This is a retrospective observational study based on TB patients diagnosed in the period 2011-2012. We used three different data sources: a) TB related variables collected by the National TB Control Program in the district of Manhiça for all TB cases starting treatment in the period 2011-2012. b) Population estimates for the district were obtained through the Mozambican National Statistics Institute. c) Deaths and other relevant demographic variables were collected from the Health and Demographic Surveillance System at Manhiça Health Research Center. WHO guidelines were used to define TB cases and treatment outcomes. Of the 1957 cases starting TB treatment in the period 2011-2012, 294 patients (15.1 %) died during anti-tuberculous treatment. Ten per cent of patients defaulted treatment. The proportion of patients considered to have treatment failure was 1.1 %. HIV infection (OR 2.73; 95 % CI: 1.70-4.38), being female (OR: 1.39; 95 % CI: 1.31-1.91) and lack of laboratory confirmation (OR 1.51; 95 % CI: 1.10-2.08) were associated with dying during the course of TB treatment (p value <0.05). The contribution of TB to the overall death burden of the district for natural reasons was 6.5 % (95 % CI: 5.5-7.6), higher for males than for females (7.8 %; 95 % CI: 6.1-9.5 versus 5.4 %; 95 % CI: 4.1-6.8 respectively). The age group within which TB was responsible for the highest proportion of deaths was 30-34 among males and 20-24 among females (20 % of all deaths in both cases). This study shows a very high proportion of fatal outcomes among TB cases starting treatment. There is a high contribution of TB to the overall causes of mortality. These results call for action in order to improve TB (and TB/HIV) management and thus treatment outcomes of TB patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mozambique 1 <1%
Spain 1 <1%
Unknown 129 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 41 31%
Researcher 13 10%
Student > Ph. D. Student 13 10%
Student > Bachelor 11 8%
Other 7 5%
Other 18 14%
Unknown 28 21%
Readers by discipline Count As %
Medicine and Dentistry 50 38%
Nursing and Health Professions 19 15%
Biochemistry, Genetics and Molecular Biology 5 4%
Immunology and Microbiology 4 3%
Social Sciences 4 3%
Other 16 12%
Unknown 33 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2016.
All research outputs
#13,396,446
of 22,873,031 outputs
Outputs from BMC Infectious Diseases
#3,300
of 7,689 outputs
Outputs of similar age
#171,879
of 333,293 outputs
Outputs of similar age from BMC Infectious Diseases
#66
of 155 outputs
Altmetric has tracked 22,873,031 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,689 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,293 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 155 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.